Back to Search Start Over

A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.

Authors :
Wan‐Ching Yen
William W. Lamph
Source :
Prostate; Feb2006, Vol. 66 Issue 3, p305-316, 12p
Publication Year :
2006

Details

Language :
English
ISSN :
02704137
Volume :
66
Issue :
3
Database :
Complementary Index
Journal :
Prostate
Publication Type :
Academic Journal
Accession number :
19625009
Full Text :
https://doi.org/10.1002/pros.20347